N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE DECREASED

This adverse event was reported 28 times

These drugs are most commonly taken by patients reporting N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE DECREASED:

# Drug Count
0 BORTEZOMIB 9
1 IXAZOMIB 9
2 LENALIDOMIDE 9
3 SACUBITRIL AND VALSARTAN 9
4 DEXAMETHASONE 7
5 DEXAMETHASONE 1.5 MG 7
6 EMPAGLIFLOZIN 5
7 DICLOFENAC 3
8 DICLOFENAC SODIUM 3
9 EPLERENONE 3
See all common drugs associated with N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE DECREASED

N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALENDRONATE SODIUM AND CHOLECALCIFEROL 1 0.0004
1 VUTRISIRAN 1 0.0003
2 IXAZOMIB 9 0.0003
3 EPLERENONE 3 0.0002
4 BORTEZOMIB 9 0.0001
5 DEXAMETHASONE SODIUM PHOSPHATE 1 0.0001
6 SACUBITRIL AND VALSARTAN 9 0.0001
7 EMPAGLIFLOZIN 5 0.0001
8 CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE 1 0.0000
9 TRAMETINIB 1 0.0000
See all drugs enriched for association with N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE DECREASED

N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Proteasome Inhibitor [EPC] 9 0.0001
1 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 5 0.0000
2 Angiotensin 2 Receptor Blocker [EPC] 9 0.0000
3 Aldosterone Antagonist [EPC] 4 0.0000
4 Thalidomide Analog [EPC] 9 0.0000
5 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
6 Loop Diuretic [EPC] 3 0.0000
7 Corticosteroid [EPC] 8 0.0000
8 Estrogen [EPC] 1 0.0000
9 Endothelin Receptor Antagonist [EPC] 1 0.0000
See all drug classes enriched for association with N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE DECREASED